CYP2S1
Basic information
Region (hg38): 19:41193210-41207539
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYP2S1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 34 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 34 | 2 | 2 |
Variants in CYP2S1
This is a list of pathogenic ClinVar variants found in the CYP2S1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-41193277-G-A | not specified | Uncertain significance (Sep 22, 2023) | ||
19-41193287-C-T | not specified | Uncertain significance (Aug 02, 2022) | ||
19-41193319-C-A | not specified | Uncertain significance (Aug 17, 2021) | ||
19-41193335-C-T | not specified | Uncertain significance (May 25, 2022) | ||
19-41193352-G-T | not specified | Uncertain significance (May 06, 2024) | ||
19-41194544-C-T | not specified | Likely benign (Dec 28, 2023) | ||
19-41194563-C-T | not specified | Uncertain significance (Jun 26, 2023) | ||
19-41194565-G-T | not specified | Uncertain significance (Oct 27, 2022) | ||
19-41194592-C-T | not specified | Uncertain significance (Nov 17, 2022) | ||
19-41194647-A-G | not specified | Uncertain significance (Jun 16, 2024) | ||
19-41194664-G-A | not specified | Uncertain significance (May 11, 2022) | ||
19-41194668-G-A | not specified | Uncertain significance (May 23, 2023) | ||
19-41197844-G-A | not specified | Uncertain significance (Oct 05, 2022) | ||
19-41197858-G-A | Benign (Dec 28, 2017) | |||
19-41197863-G-A | not specified | Uncertain significance (Nov 07, 2022) | ||
19-41197865-G-C | not specified | Uncertain significance (Oct 10, 2023) | ||
19-41197871-G-A | not specified | Uncertain significance (Dec 20, 2023) | ||
19-41197905-T-C | not specified | Uncertain significance (Jul 12, 2023) | ||
19-41198476-C-T | not specified | Uncertain significance (May 20, 2024) | ||
19-41198491-G-C | not specified | Uncertain significance (Oct 07, 2022) | ||
19-41198575-C-T | not specified | Uncertain significance (Aug 28, 2023) | ||
19-41198763-C-T | not specified | Uncertain significance (Mar 16, 2024) | ||
19-41198803-G-A | not specified | Likely benign (Mar 15, 2024) | ||
19-41198825-G-C | Likely benign (Jul 01, 2022) | |||
19-41198829-C-G | not specified | Uncertain significance (Mar 02, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYP2S1 | protein_coding | protein_coding | ENST00000310054 | 9 | 14491 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000481 | 0.968 | 125701 | 0 | 47 | 125748 | 0.000187 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.922 | 260 | 305 | 0.851 | 0.0000196 | 3175 |
Missense in Polyphen | 81 | 108.29 | 0.74801 | 1206 | ||
Synonymous | 0.654 | 127 | 137 | 0.929 | 0.00000854 | 1138 |
Loss of Function | 1.94 | 10 | 19.1 | 0.522 | 9.68e-7 | 206 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000123 | 0.000123 |
Ashkenazi Jewish | 0.00229 | 0.00228 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000142 | 0.000141 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000163 | 0.0000980 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Has a potential importance for extrahepatic xenobiotic metabolism.;
- Pathway
- Retinol metabolism - Homo sapiens (human);nicotine degradation III;Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human);Vitamin D Receptor Pathway;Oxidation by Cytochrome P450;Metapathway biotransformation Phase I and II;Phase I - Functionalization of compounds;bupropion degradation;acetone degradation I (to methylglyoxal);Xenobiotics;Tyrosine metabolism;Androgen and estrogen biosynthesis and metabolism;Miscellaneous substrates;Cytochrome P450 - arranged by substrate type;Leukotriene metabolism;Biological oxidations;Metabolism;Linoleate metabolism;C21-steroid hormone biosynthesis and metabolism;Xenobiotics metabolism;superpathway of tryptophan utilization;CYP2E1 reactions;melatonin degradation I;superpathway of melatonin degradation;Arachidonic acid metabolism;nicotine degradation IV
(Consensus)
Intolerance Scores
- loftool
- 0.562
- rvis_EVS
- 0.05
- rvis_percentile_EVS
- 57.48
Haploinsufficiency Scores
- pHI
- 0.180
- hipred
- N
- hipred_score
- 0.241
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.208
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cyp2s1
- Phenotype
- normal phenotype;
Gene ontology
- Biological process
- organic acid metabolic process;xenobiotic metabolic process;epoxygenase P450 pathway;exogenous drug catabolic process;oxidation-reduction process
- Cellular component
- cytoplasm;endoplasmic reticulum;endoplasmic reticulum membrane;organelle membrane;intracellular membrane-bounded organelle
- Molecular function
- iron ion binding;protein binding;arachidonic acid epoxygenase activity;steroid hydroxylase activity;retinoic acid 4-hydroxylase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;heme binding;aromatase activity